We have provided evidence that either Cdk4 or Cdk6 knockout triggers DNA damage of cancer cells and retards tumor growth in vivo through activation of STING-dependent type I interferon induction pathway and anti-tumor immune responses. Here, CDK4 is linked to neoplasm.